Dexamethasone (6 mg/m(2)/day) and prednisolone (60 mg/m(2)/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Dexamethasone could be more effective than prednisolone at similar anti-inflammatory doses in the treatment of childhood acute lymphoblastic leukemia. In order to check if this “superiority” of dexamethasone might be dose-dependent, we conducted a randomized phase III trial comparing dexamethasone (...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Domenech, Carine, Suciu, Stefan, De Moerloose, Barbara, Mazingue, Françoise, Plat, Geneviève, Ferster, Alina, Uyttebroeck, Anne, Sirvent, Nicolas, Lutz, Patrick, Yakouben, Karima, Munzer, Martine, Röhrlich, Pierre, Plantaz, Dominique, Millot, Frederic, Philippet, Pierre, Dastugue, Nicole, Girard, Sandrine, Cavé, Hélène, Benoit, Yves, Bertrandfor, Yves
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2014
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077084/
https://ncbi.nlm.nih.gov/pubmed/24727815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.103507
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak